About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1184 record(s)
Req # A-2020-000550
Adverse Reaction Reports (AERs) for PETHIDINE HYDROCHLORIDE. Report numbers: 733573, E2B_02963314, E2B_02899597.Organization: Health Canada
November 2020
Req # A-2020-000570
Adverse Reaction Report (AER) for botulinum toxin. Report number: E2B_03052678.Organization: Health Canada
November 2020
Req # A-2020-000585
Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03143688Organization: Health Canada
November 2020
Req # A-2020-000589
Adverse Reaction Report (AER) for Botulinum toxin. Report number: E2B_03068886.Organization: Health Canada
November 2020
Req # A-2020-000595
Adverse Reaction Report (AER) for botulinum toxin. Report number: E2B_03131898.Organization: Health Canada
November 2020
Req # A-2020-000613
Adverse Reaction Reports (AERs). Report numbers: E2B_03133267, E2B_03150308.Organization: Health Canada
November 2020
Req # A-2020-000617
Adverse Reaction Reports (AERs). Report numbers: E2B_03071563, E2B_03072977, E2B_03074304, E2B_03074429.Organization: Health Canada
November 2020
Req # A-2020-000719
Adverse Reaction Reports (AERs) for Mesalazine. Report numbers: E2B_03034109, E2B_03034115, E2B_03034116, E2B_03034117, E2B_03034118, E2B_03034122, E2B_03035579, 000910919, E2B_03054315, E2B_03054673, E2B_03072859, E2B_03074626, E2B_03074952,…Organization: Health Canada
November 2020
Req # A-2020-000720
Adverse Reaction Reports (AERs) for Mesalazine. Report numbers: E2B_03143352, E2B_03149455, E2B_03154815, E2B_03166561, E2B_03166583, E2B_03169169 , E2B_03169172 , E2B_03170001. AER for Antihemophilic factor (recombinant). Report number:…Organization: Health Canada
November 2020
Req # A-2020-000728
Adverse Reaction Report (AER) for IXAZOMIB. Report number: E2B_03196983. AERs for ONDANSETRON. Report numbers: 000916283, E2B_03212229, E2B_03215055, E2B_03218309. AERs for PANTOPRAZOLE. Report numbers: E2B_03174989, E2B_03196072, E2B_03200014,…Organization: Health Canada
November 2020